Respiratory Therapeutic Devices Market Analysis

Respiratory Therapeutic Devices Market Overview

Respiratory Therapeutic Devices Market Size was valued at USD 8.34 Billion in 2023. The Global Respiratory Therapeutic Devices industry is projected to grow from USD 8.67 Billion in 2024 to USD 14.34 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.34% during the forecast period (2024 - 2032).

Respiratory therapeutic devices such as the oxygen concentrator, nebulizer, ventilators and others have become mandatory equipment in almost every hospital, which is increasing Respiratory Therapeutic Devices Market Share. The government's investment in healthcare expenditure is a major market growth factor. The rise in the adoption of different therapeutic devices in home care settings fuels the market. 

Due to the global pandemic, there was a sudden huge rise in the demand for respiratory therapeutic devices, which boosted up the Respiratory Therapeutic Devices Market. The driving factors resulting in the market's increased growth, such as the high prevalence of respiratory diseases and tobacco smoking, increased rate of urbanization and growing levels of air pollution, and lifestyle changes, will help the Market to reach a good value during the forecasted period. 

Respiratory assist devices are intended for helping patients in need of support for breathing, carbon dioxide removal, and therapy for reducing disuse atrophy of abdominal wall muscles. The FDA issued EUAs for helping the increase in the availability of respiratory assist devices, which are integral for treating patients during the pandemic.

One example is when, in November 2022, a company called Xplore Health Technologies released its maiden device for breathing muscles’ recovery/increasing their strength, named Airofit Pro. It’s a result of the teamwork with Denmark’s Airofits. It was among the earliest information-driven clever airway exercise systems, sold at $422.74 or Rs 34990 in Indian Rupees.

For example, in November 2022, BioIntelliSense announced its pulse oximetry sensor chipset that was patented and integrated with processing technology that can measure blood oxygen levels across different skin colors starting from lightest to darkest ones, where the US FDA cites concerns about racial disparity related finger-tip devices while moving or exercising.

Boehringer Ingelheim, in July 2022 partnered with VisionHealth on the Kara app that could help patients struggling with asthma and chronic obstructive pulmonary diseases. The Kata app is a digital platform that is able to provide targeted inhalation support for chronic respiratory disease patients.

For instance, as per clinicaltrials.gov, the study sponsored by Raydiant Oximetry, Inc. was initiated in July 2022 and is expected to be completed by December 2023. The Raydiant Oximetry Sensing System (Lumerah) is a non-invasive fetal pulse oximeter that measures fetal arterial oxygen saturation using safe, non-invasive transabdominal near-infrared spectroscopy. The study aims to verify the accuracy of the sensors. If these trials are successful, they could result in new products being made that would expand this part of the market.

July 2022: Smile Train, Inc., with its long-term partner Lifebox, introduced the Lifebox-Smile Train pulse oximeter to make it more accessible during anesthesia and critical care.

July 2022: Omron Healthcare launched a portable oxygen concentrator — their latest innovation in the oxygen therapy range — Oxygen Concentrator. This device works on medical molecular sieve principles and supplies high-purity oxygen every second.

For instance, in June 2022, CAIRE launched a portable oxygen concentrator in the U.S. LifeStyle to significantly improve the quality of life of oxygen users across the country. 

COVID-19 Analysis

During the COVID-19 pandemic, many hospitals were established to treat the patients, which were vigorously increasing. Many prominent regions started building hospitals for COVID patients. The coronavirus was majorly affecting the lungs, which increased the demand for critical care devices such as respiratory therapeutic devices. The manufacturing of these devices increased due to their higher demand, and this factor has propelled the growth of the Respiratory Therapeutic Devices Market. The government was also highly invested in the manufacture of respiratory care devices. 

As the disease was an infectious respiratory disease, it chiefly drove the market at the global level. It has resulted in the demand for personal protection equipment and ventilators, and governmental and industrial support, which has accelerated the Respiratory Therapeutic Devices Market Growth.

One example is when, in November 2022, a company called Xplore Health Technologies released its maiden device for breathing muscles’ recovery/increasing their strength, named Airofit Pro. It’s a result of the teamwork with Denmark’s Airofits. It was among the earliest information-driven clever airway exercise systems, sold at $422.74 or Rs 34990 in Indian Rupees.

For example, in November 2022, BioIntelliSense announced its pulse oximetry sensor chipset that was patented and integrated with processing technology that can measure blood oxygen levels across different skin colors starting from lightest to darkest ones, where the US FDA cites concerns about racial disparity related finger-tip devices while moving or exercising.

Boehringer Ingelheim, in July 2022 partnered with VisionHealth on the Kara app that could help patients struggling with asthma and chronic obstructive pulmonary diseases. The Kata app is a digital platform that is able to provide targeted inhalation support for chronic respiratory disease patients.

For instance, as per clinicaltrials.gov, the study sponsored by Raydiant Oximetry, Inc. was initiated in July 2022 and is expected to be completed by December 2023. The Raydiant Oximetry Sensing System (Lumerah) is a non-invasive fetal pulse oximeter that measures fetal arterial oxygen saturation using safe, non-invasive transabdominal near-infrared spectroscopy. The study aims to verify the accuracy of the sensors. If these trials are successful, they could result in new products being made that would expand this part of the market.

July 2022: Smile Train, Inc., with its long-term partner Lifebox, introduced the Lifebox-Smile Train pulse oximeter to make it more accessible during anesthesia and critical care.

July 2022: Omron Healthcare launched a portable oxygen concentrator — their latest innovation in the oxygen therapy range — Oxygen Concentrator. This device works on medical molecular sieve principles and supplies high-purity oxygen every second.

For instance, in June 2022, CAIRE launched a portable oxygen concentrator in the U.S. LifeStyle to significantly improve the quality of life of oxygen users across the country.

Respiratory Therapeutic Devices Market Trends

• Key Market Drivers

The growth drivers of the Respiratory Therapeutic Devices Market are responsible for lifting up its growth rate. The cost advantages of home therapeutics devices are the key factors driving the market. Major reasons such as the rise in healthcare costs a huge number of patients suffering from chronic respiratory diseases are other major driving factors. The growing demand for products such as nebulizers, ventilators, and CPAP devices, for treatment, diagnosis, and monitoring the patients suffering from respiratory diseases in-home care settings is highly driving the market.

• Market Challenges

The Respiratory Therapeutic Devices Market is facing challenges affecting its growth rate. The lower awareness rate among people about respiratory infectious disease is challenging the market. A huge number of lung-related diseases are still underdiagnosed and undertreated due to the lack of awareness. Due to this, people are also not receiving timely treatment. The unavailability of adequate resources for diagnosing the disease is even challenging the Market. 

• Market Opportunities

There are rising growth opportunities that are fueling the Respiratory Therapeutic Devices Market at the global level. The increased demand for home care therapeutic devices and the growth of the senior population, along with the increased rate of chronic respiratory diseases, are letting the market emerge. The higher growth in emerging markets, decentralization of healthcare, and the invention and improvement of miniaturized devices are responsible for providing significant growth opportunities. 

• Market Restraints

Patients depend on reimbursements for treatment. The diagnostic industry is presently facing challenges due to a lack of reimbursements for various diagnostic tests. This factor is restricting theRespiratory Therapeutic Devices Market growth. Also, the mainstream countries have negligible reimbursement coverage for respiratory therapeutic devices, which is acting as a restraining factor.

Cumulative Evaluation Of The Market

The evaluation of the Respiratory Therapeutic Devices Market Analysis states about the market's growth at the global level. The presence of market dynamics such as the growth drivers and opportunities surges the market's growth. At the same time, the challenging factors and restraints of the market are limiting its growth rate. The player's development and other strategies will help the market reach good share value. The pandemic has positively impacted the market due to the higher demand for respiratory therapeutic devices. During the pandemic, the market's growth rate increased and ensured achieving the estimated CAGR value. Even in the post-pandemic period.

Respiratory Therapeutic Devices Market Segment Insights

The Respiratory Therapeutic Devices Market Size is segregated into the product, technology, application, and end-users.

Respiratory Therapeutic Devices Product Insights

The product segment of the market is classified into various products such as nebulizers, capnography, humidifiers oxygen concentrators, and others. The nebulizers segment is divided into soft mist inhalers, human-powered nebulizers, and others. The capnography is also sub-segmented into main-stream and side-stream capnography, and others.

Respiratory Therapeutic Devices Technology Insights

The technology segment of the market is fragmented into hollow fiber filtration, electrostatic filtration, HEPA filtration, microsphere separation, and others.

Respiratory Therapeutic Devices Application Insights

The application section of the market is divided into asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD), and others.

Respiratory Therapeutic Devices End-Users Insights

The end-user segment is bifurcated into hospitals and clinics, retail pharmacies, home care, etc.

Respiratory Therapeutic Devices Regional Insights

According to the geographical distribution of the Respiratory Therapeutic Devices Market, it is divided into major regions such as the Americas, Europe, Asia Pacific and the Middle East and Africa.

Among the above regions, the Americas are leading the market due to a well-developed healthcare sector and an increased rate of lung diseases. The lifestyles changes and increase in healthcare investments are boosting up the regional market growth of the specific region. The presence of prominent industrial players in the emerging countries, the U.S. and Canada, are accelerating regional growth. 

Followed by America, the European region is considered the second largest market due to the well-established healthcare infrastructure. Government support towards research and development activities with a huge patient population is driving the regional market. Developing countries such as Germany, the U.K, and France are fueling up the market.

The Asia Pacific is considered the fastest-growing region due to a huge patient population of lung diseases; developing countries like India and China are setting huge opportunities for the APAC market. Even the favorable government policies such as the reduced excise and customs duty along with exemptions in service tax are boosting up the market. 

The Middle East and Africa are holding the least market share due to the poor economic condition, absence of a developed healthcare sector and stringent policies by the government that are restraining its regional growth. The Middle East region holds the maximum share due to the huge healthcare expenditures and the presence of countries like Kuwait, Saudi Arabia, Dubai, and Qatar.

Competitive Intensity Within The Industry

The key players of the Market are responsible for the market's development and establishment. The competition between the players and their presence in a different region of the world is accelerating the global market. The players' acquisitions, partnerships, collaborations, and new product launches are improving the Respiratory Therapeutic Devices Market Trends and performance.

• Masimo. (the U.S.)


• BD. (U.S.)


• Smiths Group Plc. (the U.S.)


• F. Hoffmann-La Roche Ltd (Europe)


• Bayer AG (Europe)


• Rotech Healthcare Inc. (U.S.)


• Chart Industries (U.S.)


• ACare Technology (Asia Pacific)

Recent Market Developments

• In August 2021, ResMed launched AirSense11, a next-generation PAP therapy device. It has a remote software update that eases into therapy and provides comfort during nighttime. 


• In November 2021, Cipla launched Spirofy, which is a portable, wireless spirometer. It has bacterial and viral filters that make the user comfortable for outdoor camps and remote regions with power shortages. 

Report Overview

The Respiratory Therapeutic Devices Market Forecast report states the complete market's growth in recent years. The market dynamics show their impact on the market as per their characteristic feature. The report also states about the market segments and regional growth. The segmentation report states the major segments, while the regional analysis shows the prominent regions covered along with the market's regional growth. The presence of major industrial players is responsibly accelerating its global growth. The recent and future developments will help the market prove its presence at the competitive level. The overall study states that the Respiratory Therapeutic Devices Market Outlook will successfully achieve its estimated compound annual growth rate during the forecast period.

Respiratory Therapeutic Devices Market Segmentation

Respiratory Therapeutic Devices Product Outlook

• Nebulizers


• Capnography


• Humidifiers Oxygen Concentrators 


• Others

Respiratory Therapeutic Devices Technology Outlook 

• Hollow Fiber Filtration


• Electrostatic Filtration


• HEPA Filtration


• Microsphere Separation


• Others 

Respiratory Therapeutic Devices Application Outlook

• Asthma


• COPD - chronic obstructive pulmonary disease


• Cystic Fibrosis

Respiratory Therapeutic Devices End Users Outlook 

• Hospitals


• Home Care